Fmoc-N-Me-Ala-OH, >98%, 5g

4-BROMO-7-FLUOROISOQUINOLINE, 95.0%, 50mg

(4-Propionylphenyl)boronic acid, 95.0%, 1g

(1S,2R)-2-PHENYLCYCLOPROPANAMINE HCL, 95.0%, 1g

2-Bromo-5-cyclopropyl-1h-imidazole, 98%, 250mg

7-Nitro-4-(pyridin-2-ylmethyl)-2H-benzo[b][1,4]oxazin-3(4H)-one, 95+%, 5g

6-Bromo-3-methylpyrazolo[1,5-a]pyrimidine, 97%, 1g

Ethyl 4-(4-nitrophenyl) benzoate, 95.0%, 1g

1,2-Di(pyrimidin-2-yl)disulfane, 95%, 1g

Monosodium Risedronate Hemipentahydrate>98.0%(HPLC)(T)1g

4-Bromobenzeneboronic acid, 97.0%, 100g

Methyl 5-Chloro-2-nitrobenzoate>98.0%(GC)5g

Estere etilico dell'acido benzoico, minimo 99%, per sintesi, 250 ml, confezione in vetro